Accessibility StatementSkip Navigation Learn more at: www.evogene.com. Logo: https://mma.prnewswire.com/media/2814604/Evogene_Logo.jpg Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the ...